|
ZKSCAN5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.275600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.679600E-02 |
| Normal-vs-Stage2 |
2.155700E-02 |
| Normal-vs-Stage3 |
7.88000000000455E-05 |
| Normal-vs-Stage4 |
1.249700E-02 |
| Stage1-vs-Stage2 |
2.066600E-01 |
| Stage1-vs-Stage3 |
3.444700E-03 |
| Stage1-vs-Stage4 |
1.285810E-01 |
| Stage2-vs-Stage3 |
3.958200E-01 |
| Stage2-vs-Stage4 |
9.484800E-01 |
| Stage3-vs-Stage4 |
4.083000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.119660E-03 |
| Normal-vs-AfricanAmerican |
9.547600E-02 |
| Normal-vs-Asian |
4.057900E-03 |
| Caucasian-vs-AfricanAmerican |
6.942000E-01 |
| Caucasian-vs-Asian |
1.144640E-03 |
| AfricanAmerican-vs-Asian |
5.562700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.757040E-03 |
| Normal-vs-Female |
2.108000E-02 |
| Male-vs-Female |
3.811600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.655800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.834100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.341730E-03 |
| Normal-vs-Age(81-100Yrs) |
3.679900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.418400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.479400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.755200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.388600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.431210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.948200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.450600E-01 |
| Normal-vs-Grade 2 |
2.984300E-02 |
| Normal-vs-Grade 3 |
6.848100E-04 |
| Normal-vs-Grade 4 |
1.022330E-02 |
| Grade 1-vs-Grade 2 |
1.400580E-01 |
| Grade 1-vs-Grade 3 |
4.895700E-02 |
| Grade 1-vs-Grade 4 |
9.686100E-02 |
| Grade 2-vs-Grade 3 |
1.098810E-01 |
| Grade 2-vs-Grade 4 |
2.210000E-01 |
| Grade 3-vs-Grade 4 |
8.144800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.481900E-02 |
| Normal-vs-ccB subtype |
1.322000E-02 |
| ccA subtype-vs-ccB subtype |
4.122600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.917100E-03 |
| Normal-vs-N1 |
7.900400E-01 |
| N0-vs-N1 |
6.609000E-01 |
|
|
